Google parent Alphabet (NSDQ:GOOGL) is relaunching its Google Glass smartglasses with a focus on industry and enterprise applications, including healthcare, according to a recent post from its moonshot subsidiary X.
X said it has been testing an industry-focused version of Glass with a number of companies, ranging from manufacturing and industrial applications and including a large number of healthcare groups.
In a blog post from last week, Glass project lead Jay Kothari said that Augmedix, a company entirely formed around Google’s Glass device, had been working with doctors at a number of different facilities to test and implement it system, which it refers to as a “remote scribe.”
The Augmedix system allows for automated note taking during physician consultations, according to the post, allowing for better patient interactions and saved time.
Doctors at Sutter Health and Dignity Health reported that the tech, powered through the Glass device, was reducing health record data entry time for up to 2 hours, and allowing for improved time management, according to the post.
X Glass has partnered with CHI Health, Christiana Care Health Systems, Dignity Health, Eastern Maine Medical Center, Klosterfrau Healthcare Group, Sutter Health, TriHealth and Trinity Health to test the Glass technology, according to its website.
The company has also partnered with medical telepresence developers Hodei Tech and SwyMed, neuroscience-based augmented reality developer Brain Power which aims to support individuals with autism, traumatic brain injury and others and Aira, a company developing assistive programs for blind and low-vision individuals.